Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) EPS (Basic) (2021 - 2026)

HeartSciences filings provide 6 years of EPS (Basic) readings, the most recent being -$0.63 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 75.49% to -$0.63 in Q1 2026 year-over-year; TTM through Jan 2026 was -$4.94, a 32.97% increase, with the full-year FY2025 number at -$9.34, up 50.16% from a year prior.
  • EPS (Basic) hit -$0.63 in Q1 2026 for HeartSciences, up from -$0.85 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.11 in Q2 2024 to a low of -$79.36 in Q2 2023.
  • Median EPS (Basic) over the past 5 years was -$1.58 (2025), compared with a mean of -$7.38.
  • Biggest five-year swings in EPS (Basic): tumbled 12909.84% in 2023 and later skyrocketed 100.14% in 2024.
  • HeartSciences' EPS (Basic) stood at -$0.22 in 2022, then plummeted by 7136.36% to -$15.92 in 2023, then surged by 85.74% to -$2.27 in 2024, then surged by 62.56% to -$0.85 in 2025, then grew by 25.88% to -$0.63 in 2026.
  • The last three reported values for EPS (Basic) were -$0.63 (Q1 2026), -$0.85 (Q4 2025), and -$1.58 (Q3 2025) per Business Quant data.